Liver-Directed Therapy Combined with Systemic Therapy: Current Status and Future Directions

Area of Science:

• Oncology
• Hepatology
• Cancer Therapy

Background:

• Modern cancer treatment increasingly involves multidisciplinary approaches, combining systemic and locoregional therapies.
• The liver is a common site for primary and secondary cancers, necessitating complex treatment strategies.

Purpose of the Study:

• To review the current data on combined locoregional and systemic therapies for liver cancers.
• To discuss the strengths, weaknesses, and future directions for these combined treatment modalities.

Main Methods:

• Literature review of studies investigating combined locoregional and systemic therapies.
• Analysis of treatment outcomes for hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.

Main Results:

• Combined therapies show promise in controlling systemic disease and targeting refractory cancer cells.
• Concerns regarding increased toxicity, patient selection, and treatment sequencing persist.

Conclusions:

• Combined locoregional and systemic therapies are gaining favor for liver cancers.
• Further research is essential to address toxicity, optimize patient selection, and refine treatment sequencing for improved outcomes.